Новости портфельных компаний

  • 01 Августа 2013

    ReVision Optics привлекла $55 млн инвестиций

    ReVision Optics привлекла $55 млн инвестиций

     Компания ReVision Optics, Inc. (RVO), лидер в области разработок имплантатов роговицы глаза для лечения пресбиопии, объявила, что привлекла $55 млн инвестиций в акционерный капитал от синдиката инвесторов, в состав которого входят инвесторы предыдущих раундов Canaan Partners, ProQuest Investments, InterWest Partners and Domain Associates и новые инвесторы Johnson & Johnson Development Corporation (JJDC) и РоснаноМедИнвест (RMI).

  • 25 Июня 2013

    ReVision Optics: European study shows positive results for inlay in emmetropic presbyopic patients

    ReVision Optics: European study shows positive results for inlay in emmetropic presbyopic patients

    Results of the EuroKLEAR multicenter showed the safety and efficacy of the ReVision Optics Raindrop aspheric corneal inlay in emmetropic presbyopic patients.

  • 04 Февраля 2013

    Nanotechnology Didn't Shrink and Disappear; In Fact, It's Everywhere

    Nick Rockel, Institutional Investor

    Nanotechology, which involves controlling matter at the molecular and atomic levels, was a much-hyped investment theme a decade ago. It’s since become widely used in commercial products ranging from solar panels to semiconductors, but investing in nanotech requires patience.

  • 01 Февраля 2013

    Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets

    Andrew Patterson meets a kiwi bio-tech company which has raised $74 million developing a therapeutic drug here for international markets

    Tracey Sunderland, COO, Coda Therapeutics Inc: “We think we’ve got something that has the potential to be a real game changer in this space particularly due to the fact that there are no therapeutic compounds on the market currently.”

  • 09 Января 2013

    San Diego Life Sciences Roundup: Trius, CoDa, Zacharon, & More

    Bruce V. Bigelow, Xconomy

    The annual International CES in Las Vegas again featured a Digital Health Summit, which included a number of San Diego-based startups. Rick Valencia of Qualcomm Life posted an interesting blog here, and an end-of-year report from Rock Health showed that investments in digital health startups increased more than 44 percent in 2012, to $1.4 billion from $968 million in 2011.

  • 07 Января 2013

    Marinus Pharmaceuticals Adds $21M Series C

    Marinus Pharmaceuticals Adds $21M Series C

    Marinus Pharmaceuticals, Inc. is pleased to announce $21 million in new Series C financing from U.S. venture capital firm Domain Associates, LLC, Rusnano subsidiary RusnanoMedInvest (RMI), and co-investors.

  • 20 Декабря 2012

    Regado Biosciences, Inc. secures $51 million series e financing

    Regado Biosciences, Inc. secures $51 million series e financing

    Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced it has secured a landmark $51 million Series E financing. New Investor Leads Round to Fund Phase 3 Development of REG1

  • 20 Декабря 2012

    Lithera, Inc. Completes $20.6 Million Equity Financing

    Lithera, Inc. Completes $20.6 Million Equity Financing

    Lithera, Inc. today announced investment of $20.6 million in preferred stock equity financing. The investment was led by RusnanoMedInvest (“RMI” a subsidiary of RUSNANO) made in connection with a joint investment collaboration with Domain Associates.

  • 24 Июля 2012

    CoDa Therapeutics Completes $49 Million Fund Raising

    CoDa Therapeutics Completes $49 Million Fund Raising

    CoDa Therapeutics, Inc. announced today that it raised an additional NZ$24.5M from Russian investment firm RusnanoMedInvest (“RMI”). This brings the company’s total Series B Round to nearly NZ$49 million following a first close late last year.

  • 06 Октября 2011

    Square 1 Announces $6 Million Credit Facility to CoDa Therapeutics, Inc.

    Square 1 Bank, the exclusive banking partner to entrepreneurs and the venture capital community, is pleased to partner with CoDa Therapeutics, Inc. in providing a $6 million term loan.

Все Портфель

Медиа центр

  • НоваМедика и Pfizer стали победителями «Платиновой Унции» в номинации «Сделка года»

    НоваМедика и Pfizer стали победителями «Платиновой Унции» в номинации «Сделка года»

    НоваМедика, российская фармацевтическая компания, и Pfizer, один из лидеров мировой биофармацевтической отрасли, признаны победителями открытого профессионального конкурса «Платиновая Унция» в номинации «Сделка года» за соглашение о долгосрочном сотрудничестве, предполагающем строительство высокотехнологичного фармацевтического производства и локализацию в России более 30 жизненно-важных препаратов.

Перейти в медиа-центр